Hepatitis B Immune Globulin (HBIG) from China
HBIG is a human plasma-derived blood fraction rich in antibodies to hepatitis B surface antigen, used for post-exposure prophylaxis. Under HTS 3002.12.00 as antisera for therapeutic and prophylactic applications. It provides immediate protection in high-risk scenarios like needlestick injuries.
Duty Rate — China → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Include serologic testing results confirming antibody specificity and titer
• Declare as 'sterile solution' to align with pharma import lanes
• Avoid mixing with vaccines to prevent reclassification as 3002.20 product